MRK
Merck & Company IncNYSEHEALTHCAREDRUG MANUFACTURERS - GENERAL
Key Statistics
Market Cap
$287.71B
P/E Ratio
15.98
EPS
$7.28
Beta
0.26
52W High
$124.22
52W Low
$70.74
50-Day MA
$115.86
200-Day MA
$95.02
Dividend Yield
2.80%
Profit Margin
28.10%
Forward P/E
22.32
PEG Ratio
3.48
About Merck & Company Inc
Merck & Co. is an American multinational pharmaceutical company headquartered in Kenilworth, New Jersey. It is named after the Merck family, which set up Merck Group in Germany in 1668.
Fundamentals
| Revenue (TTM) | $65.01B |
| Gross Profit (TTM) | $50.20B |
| EBITDA | $29.11B |
| Operating Margin | 32.80% |
| Return on Equity | 36.90% |
| Return on Assets | 12.00% |
| Revenue/Share (TTM) | $25.98 |
| Book Value | $21.26 |
| Price-to-Book | 5.37 |
| Price-to-Sales (TTM) | 4.43 |
| EV/Revenue | 4.877 |
| EV/EBITDA | 11.22 |
| Quarterly Earnings Growth (YoY) | -19.30% |
| Quarterly Revenue Growth (YoY) | 5.00% |
| Shares Outstanding | $2.47B |
| Float | $2.47B |
| % Insiders | 0.06% |
| % Institutions | 81.37% |
Historical Volatility
HV 10-Day
11.50%
HV 20-Day
24.44%
HV 30-Day
21.88%
HV 60-Day
22.93%
HV Rank
13.9%
Volatility is currently contracting
Analyst Ratings
Consensus ($128.04 target)
4
Strong Buy15
Buy11
HoldData last updated: 3/25/2026